Document is current

Any future updates will be listed below

Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes

Crossref DOI link: https://doi.org/10.1186/s12913-017-2561-0

Published Online: 2017-08-30

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark